Type 2 diabetes mellitus and obesity are independent risk factors for poor outcome in patients with high-grade glioma
- 11 August 2011
- journal article
- Published by Springer Science and Business Media LLC in Journal of Neuro-Oncology
- Vol. 106 (2), 383-389
- https://doi.org/10.1007/s11060-011-0676-4
Abstract
Type 2 diabetes mellitus (DM) and obesity are known risk factors for poor outcomes in patients with systemic malignancies but are not well-studied in the brain tumor population. In this study we asked if type 2 DM and elevated body mass index (BMI) are independent risk factors for poor prognosis in patients with high-grade glioma (HGG.). We conducted a retrospective cohort study of 171 patients surgically treated for HGG at a single institution. BMI and records of pre-existing type 2 DM were obtained from medical histories. Variables associated with survival in a univariate analysis were included in the multivariate Cox model if P < 0.10. Variables with probability values >0.05 were then removed from the multivariate model in a step-wise fashion. Mean age at diagnosis was 55.0 ± 17.3 years. Fifteen (8.8%) patients had a history of type 2 DM. Fifty-eight (35.8%) patients had a BMI < 25, 55 (34.0%) BMI 25–30, and 49(30.2%) BMI > 30. Radiation therapy, temozolomide, and higher KPS score were independently associated with prolonged survival while increasing age was associated with decreased survival. DM (P = 0.001) and increasing BMI (P = 0.003) were found to be independently associated with decreased survival. Diabetics had a decreased median overall survival (312 vs. 470 days, P = 0.003) and PFS (106 vs. 166 days, P = 0.04) compared to non-diabetics. Increasing BMI (30) was also associated with decreased median PFS: 195 vs. 165 vs. 143 days, respectively. Pre-existing DM and elevated BMI are independent risk factors for poor outcome in patients with HGG.Keywords
This publication has 39 references indexed in Scilit:
- Type 2 diabetes increases and metformin reduces total, colorectal, liver and pancreatic cancer incidences in Taiwanese: a representative population prospective cohort study of 800,000 individualsBMC Cancer, 2011
- Association between body mass index and mortality in patients with glioblastoma mutliformeCancer Causes & Control, 2010
- Grade-Specific Expression of Insulin-like Growth Factor–Binding Proteins-2, -3, and -5 in Astrocytomas: IGFBP-3 Emerges as a Strong Predictor of Survival in Patients with Newly Diagnosed GlioblastomaCancer Epidemiology, Biomarkers & Prevention, 2010
- Height, Body Mass Index, and Physical Activity in Relation to Glioma RiskCancer Research, 2009
- Targeting the insulin-like growth factor-1 receptor by picropodophyllin as a treatment option for glioblastomaNeuro-Oncology, 2009
- Association Between Hyperglycemia and Survival in Patients With Newly Diagnosed GlioblastomaJournal of Clinical Oncology, 2009
- Long-term All-Cause Mortality in Cancer Patients With Preexisting Diabetes MellitusJAMA, 2008
- Lifestyle factors and primary glioma and meningioma tumours in the Million Women Study cohortBritish Journal of Cancer, 2008
- Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studiesThe Lancet, 2008
- Overweight, obesity and cancer: epidemiological evidence and proposed mechanismsNature Reviews Cancer, 2004